14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $260.68 $288.54 Thursday, 25th Apr 2024 AMGN stock ended at $269.38. This is 1.33% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 2.66% from a day low at $267.24 to a day high of $274.35.
90 days $260.68 $329.72
52 weeks $211.73 $329.72

Historical Amgen Inc. prices

Date Open High Low Close Volume
Mar 20, 2024 $270.62 $273.07 $269.24 $273.05 2 552 889
Mar 19, 2024 $270.18 $273.16 $269.60 $271.73 3 036 831
Mar 18, 2024 $270.00 $273.58 $269.21 $270.90 3 591 155
Mar 15, 2024 $272.09 $275.17 $268.17 $268.87 8 761 928
Mar 14, 2024 $276.84 $276.95 $270.45 $271.54 2 365 436
Mar 13, 2024 $278.18 $278.55 $275.21 $275.99 1 632 253
Mar 12, 2024 $276.85 $278.15 $274.14 $276.54 1 738 581
Mar 11, 2024 $274.51 $278.19 $272.99 $275.36 1 845 693
Mar 08, 2024 $272.81 $276.56 $272.01 $273.75 2 235 676
Mar 07, 2024 $276.30 $276.81 $269.58 $272.86 4 054 864
Mar 06, 2024 $275.38 $278.97 $274.55 $276.59 2 236 470
Mar 05, 2024 $279.62 $279.75 $275.02 $276.65 3 047 694
Mar 04, 2024 $283.26 $285.89 $277.66 $279.39 2 451 506
Mar 01, 2024 $276.50 $281.93 $274.88 $280.33 3 768 845
Feb 29, 2024 $278.52 $279.83 $273.43 $273.83 5 799 424
Feb 28, 2024 $278.99 $280.43 $277.09 $277.46 2 966 867
Feb 27, 2024 $279.10 $281.22 $277.21 $278.49 3 346 938
Feb 26, 2024 $288.28 $289.87 $285.44 $286.37 2 445 420
Feb 23, 2024 $286.52 $292.24 $286.01 $289.18 2 458 527
Feb 22, 2024 $282.48 $285.72 $281.39 $285.18 2 989 776
Feb 21, 2024 $284.84 $285.78 $280.83 $283.46 1 923 713
Feb 20, 2024 $283.85 $285.28 $280.55 $283.51 3 395 849
Feb 16, 2024 $287.71 $287.71 $283.27 $283.70 3 593 963
Feb 15, 2024 $287.88 $290.35 $285.60 $289.07 2 901 005
Feb 14, 2024 $289.88 $290.87 $287.55 $290.07 2 615 478
Click to get the best stock tips daily for free!

About Amgen Inc.

Amgen. Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopaus... AMGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT